DermTech Connect 2.2

Now you can address a suspicious mole with ease through three simple steps: Take a photo, submit it for evaluation, and receive the assessment from an independent dermatologist via the DermTech Connect app within approximately 48 hours. The consultation fee is $39 per mole, payable exclusively by credit card. Professional services do not accept insurance, including Medicare or Medicaid.

If the dermatologist deems it necessary, they may recommend the DermTech Melanoma Test, a non-invasive genomic laboratory test, for further evaluation of the suspicious mole. For additional details on the test, please visit dermtech.com/how-it-works. The DermTech Melanoma Test qualifies as a clinical laboratory test and may be reimbursable like other laboratory tests, subject to relevant co-payments or deductibles. To verify insurance coverage for a DermTech Melanoma test, contact our Patient Concierge Team at 866-450-4223 ext. 155 from 8 am to 5 pm PT (Mon-Fri) or via email at [email protected]. For further insurance information, go to dermtech.com/patient-resources.

Early monitoring of suspicious moles can be crucial in detecting melanoma early. Act now by downloading DermTech Connect today.

DermTech Connect is NOT accessible in specific states, including Arkansas, Delaware, Idaho, Minnesota, New Hampshire, Vermont, and the District of Columbia. Accessibility may vary based on legal requirements and health provider availability.

To register for DermTech Connect, you must be at least 18 years old, and any information provided in this account belongs to you (the account holder). Use of DermTech Connect is contingent upon your acceptance of applicable terms of service, privacy policies, telehealth consent, and other conditions set by DermTech or the independent health provider. Independent health providers determine the adequacy of information provided for health services via DermTech Connect and may direct individuals to alternative care sources.

* Services offered via DermTech Connect are strictly limited to skin melanoma screening through telehealth and are not a substitute for routine preventive health care or primary care services in dermatology or other specialties.